Skip to content
Company Analysis

Alcon Inc. ALC

A comprehensive view of key metrics, scores, and financial health for Alcon Inc.

Overview of Alcon Inc.

ALC NYQ
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Large Cap
Alcon Inc. (ALC), is a Large Cap company, in the Medical Instruments & Supplies industry, last closed at $66.85, about 50.0% overvalued vs fair value, -22.4% 1Y return, placing in the top 25% of its sector.
Metrics Rev Growth 4.9% ROE 4.5% Gross Margin 55.2% Div Yield 0.39%
USD 66.85
0.51%
(Delayed)
• Vol 90d: 33.7%
52-Week Range
Market Cap
$32.13B
Enterprise Value
$35.85B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 56%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.alcon.com
HQ Geneva
Employees 25,942
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$29
$33
$38
Current: $66.85 -50% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$10.4B
4.9%%
Gross Profit
$5.7B
4.2%%
Operating Income (GAAP)
$1.4B
-3.8%%
EBITDA
$2.4B
-12.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
55.2%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$177.0M
12.6% of Free Cash Flow

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Alcon Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
71
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
69
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing ALC's balance between Growth (26.9%), Profitability (38.5%), and Safety (34.7%). Growth 27% Safety 35% Profitability 38%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

51th percentile vs peers
51
Key Signals
Rev Growth YoY 4.9% 46p EPS CAGR 3Y 39.0% 87p Revenue CAGR 3Y 6.1% 46p EPS Growth YoY 4.3% 34p TSR -6.8% 46p
Strengths
  • EPS CAGR 3Y in top 20% of peers (39.0%, 87th percentile)
  • FCF Margin in top 20% of peers (16.6%, 88th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (11.52, 80th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (4.37, 94th percentile)
  • Superior capital returns - 2 return metrics above peer median
Risks

No significant risks identified for this axis.

Profitability

73th percentile vs peers
73
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

65th percentile vs peers
66
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Alcon Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$33.43
- - -
-50.0% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000